RADHAKISHAN PHARMACEUTICALS
BORVIZ BORTEZOMIB INJECTION

BORVIZ BORTEZOMIB INJECTION

BORVIZ BORTEZOMIB INJECTION Specification

  • Origin of Medicine
  • Imported
  • Dosage Form
  • Injection
  • Indication
  • Treatment of multiple myeloma and mantle cell lymphoma
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Salt Composition
  • Bortezomib 2 mg
  • Drug Type
  • Prescription Drug
  • Ingredients
  • Bortezomib
  • Physical Form
  • Liquid Injection
  • Function
  • Anti-cancer (Antineoplastic)
  • Recommended For
  • Multiple Myeloma, Mantle Cell Lymphoma
  • Dosage
  • As directed by physician
  • Dosage Guidelines
  • Intravenous or subcutaneous administration
  • Suitable For
  • Adults
  • Quantity
  • 1 vial
  • Storage Instructions
  • Store below 25C, protect from light
  • Packaging Type
  • Vial
  • Strength
  • 2 mg/vial
  • Colour
  • Clear, colourless to faintly yellow solution
  • Brand Name
  • Borviz
  • Route of Administration
  • IV or SC (Intravenous or Subcutaneous)
  • Shelf Life
  • 24 months
  • Prescription Required
  • Yes
  • Hazardous Drug Caution
  • Cytotoxic: Handle with care
 

BORVIZ BORTEZOMIB INJECTION Trade Information

  • Packaging Details
  • PACK OF 1 VIAL
  • Main Domestic Market
  • All India
 

About BORVIZ BORTEZOMIB INJECTION

Borviz 2mg Injection

Specifications :-

  • Brand Name :- BORVIZ
  • Content:- Bortezomib
  • Strength:- 2 Mg
  • Form:- Injection
  • Packing:- Pack of 1 vial
  • Manufactured By :- INTAS



Note :- BORVIZ Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............



Powerful Anti-Cancer Action

Borviz Bortezomib Injection is specifically designed to target multiple myeloma and mantle cell lymphoma, inhibiting cancer cell growth with precision. As an antineoplastic agent, its mechanism of action involves disrupting cancerous cells life cycle, making it an essential part of modern oncological treatment.


Flexible Administration Routes

Borviz offers flexibility in administration, allowing for intravenous or subcutaneous injection based on patient needs. This versatility accommodates individualized clinical scenarios, enhancing comfort and convenience during therapy. Administration is always performed under medical supervision.


Safety and Handling Precautions

As a cytotoxic medication, Borviz requires careful handling to minimize exposure risks. Healthcare professionals adhere to strict protocols when preparing and administering the injection. It is important to follow all safety guidelines and use personal protective equipment when managing this hazardous drug.

FAQs of BORVIZ BORTEZOMIB INJECTION:


Q: How should Borviz Bortezomib Injection be administered?

A: Borviz should be administered by a qualified healthcare professional using either the intravenous (IV) or subcutaneous (SC) route, depending on the patients treatment plan as prescribed by the physician.

Q: What conditions is Borviz prescribed to treat?

A: This injection is indicated for the treatment of adults diagnosed with multiple myeloma and mantle cell lymphoma. It must be used under medical supervision and with an appropriate prescription.

Q: Where should Borviz Bortezomib Injection be stored and how can its shelf life be maintained?

A: Borviz must be stored below 25C and protected from light to maintain its potency throughout its 24-month shelf life. Always keep it in its original packaging until use.

Q: What precautions should be taken when handling Borviz?

A: As Borviz is a cytotoxic medication, it should be handled with gloves and other protective gear to avoid exposure. Preparation and administration must follow established safety procedures to ensure safe use.

Q: What is the benefit of receiving Borviz Bortezomib Injection?

A: Borviz offers effective anti-cancer benefits for patients with multiple myeloma and mantle cell lymphoma, helping to control disease progression and improve treatment outcomes under the guidance of an oncologist.

Q: Who can use Borviz Bortezomib Injection?

A: This medication is suitable for adult patients and is not recommended for children. The exact dosage and administration are determined by a healthcare provider based on individual needs.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

ZOLDRIA ZOLEDRONIC ACID INJECTION

ZOLDRIA ZOLEDRONIC ACID INJECTION

Ingredients : Zoledronic Acid

Physical Form : Liquid

Drug Type : Other, Prescription

Dosage Guidelines : Administer via intravenous infusion over at least 15 minutes, medical supervision required

Pacakaging (Quantity Per Box) : 1 vial per box

Function : Other, Prevention and treatment of osteoporosis, management of bone complications in cancer, treatment of hypercalcemia

X-VIR ENTECAVIR TABLETS

X-VIR ENTECAVIR TABLETS

Ingredients : Entecavir

Physical Form : Tablets

Drug Type : Other, Prescription

Dosage Guidelines : As directed by physician

Pacakaging (Quantity Per Box) : 30 Tablets per box

Function : Other, Antiviral

ERLONAT ERLOTINIB 150 MG TABLETS

ERLONAT ERLOTINIB 150 MG TABLETS

Ingredients : Erlotinib Hydrochloride

Physical Form : Tablets

Drug Type : Other, Allopathic

Dosage Guidelines : Take exactly as prescribed by your doctor. Do not chew or crush the tablet.

Pacakaging (Quantity Per Box) : 30 tablets

Function : Other, Anticancer (tyrosine kinase inhibitor)

ERLONAT ERLOTINIB  100 MG TABLETS

ERLONAT ERLOTINIB 100 MG TABLETS

Ingredients : Erlotinib Hydrochloride

Physical Form : Tablets

Drug Type : Other, Allopathic

Dosage Guidelines : Take on empty stomach, at least 1 hour before or 2 hours after food

Pacakaging (Quantity Per Box) : 30 Tablets

Function : Other, Anticancer (EGFR inhibitor)



Back to top